nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—CYP2C19—Methimazole—Graves' disease	0.317	0.674	CbGbCtD
Lapatinib—CYP3A4—Methimazole—Graves' disease	0.153	0.326	CbGbCtD
Lapatinib—TAP1—Antigen Presentation: Folding, assembly and peptide loading of class I MHC—HLA-E—Graves' disease	0.0173	0.0797	CbGpPWpGaD
Lapatinib—Interstitial lung disease—Propylthiouracil—Graves' disease	0.0169	0.126	CcSEcCtD
Lapatinib—TAP1—pituitary gland—Graves' disease	0.0131	0.0731	CbGeAlD
Lapatinib—TAP1—adipose tissue—Graves' disease	0.0131	0.0728	CbGeAlD
Lapatinib—ERBB2—connective tissue—Graves' disease	0.0124	0.0692	CbGeAlD
Lapatinib—TAP1—Antigen Presentation: Folding, assembly and peptide loading of class I MHC—HLA-B—Graves' disease	0.0123	0.0568	CbGpPWpGaD
Lapatinib—PIK3C2B—pituitary gland—Graves' disease	0.0123	0.0686	CbGeAlD
Lapatinib—PIK3C2B—adipose tissue—Graves' disease	0.0123	0.0683	CbGeAlD
Lapatinib—TAP1—Antigen Presentation: Folding, assembly and peptide loading of class I MHC—HLA-A—Graves' disease	0.0114	0.0526	CbGpPWpGaD
Lapatinib—TAP1—thyroid gland—Graves' disease	0.0113	0.063	CbGeAlD
Lapatinib—TAP1—Type II interferon signaling (IFNG)—CXCL10—Graves' disease	0.0107	0.0492	CbGpPWpGaD
Lapatinib—PIK3C2B—thyroid gland—Graves' disease	0.0106	0.0591	CbGeAlD
Lapatinib—ERBB4—pituitary gland—Graves' disease	0.00957	0.0533	CbGeAlD
Lapatinib—ERBB2—adipose tissue—Graves' disease	0.00953	0.0531	CbGeAlD
Lapatinib—ERBB4—adipose tissue—Graves' disease	0.00953	0.0531	CbGeAlD
Lapatinib—Renal failure acute—Propylthiouracil—Graves' disease	0.00943	0.0703	CcSEcCtD
Lapatinib—PI4KB—pituitary gland—Graves' disease	0.00896	0.05	CbGeAlD
Lapatinib—PI4KB—adipose tissue—Graves' disease	0.00893	0.0498	CbGeAlD
Lapatinib—TAP1—Type II interferon signaling (IFNG)—HLA-B—Graves' disease	0.00871	0.0401	CbGpPWpGaD
Lapatinib—ERBB2—thyroid gland—Graves' disease	0.00825	0.046	CbGeAlD
Lapatinib—ERBB4—thyroid gland—Graves' disease	0.00825	0.046	CbGeAlD
Lapatinib—EGFR—adipose tissue—Graves' disease	0.00808	0.045	CbGeAlD
Lapatinib—TAP1—ER-Phagosome pathway—HLA-E—Graves' disease	0.00799	0.0368	CbGpPWpGaD
Lapatinib—Neuropathy peripheral—Methimazole—Graves' disease	0.00773	0.0576	CcSEcCtD
Lapatinib—PI4KB—thyroid gland—Graves' disease	0.00773	0.0431	CbGeAlD
Lapatinib—TAP1—Type II interferon signaling (IFNG)—ICAM1—Graves' disease	0.00708	0.0326	CbGpPWpGaD
Lapatinib—EGFR—thyroid gland—Graves' disease	0.00699	0.039	CbGeAlD
Lapatinib—TAP1—Antigen processing-Cross presentation—HLA-E—Graves' disease	0.0066	0.0304	CbGpPWpGaD
Lapatinib—Neuropathy peripheral—Propylthiouracil—Graves' disease	0.00658	0.049	CcSEcCtD
Lapatinib—Alopecia—Methimazole—Graves' disease	0.00626	0.0466	CcSEcCtD
Lapatinib—TAP1—ER-Phagosome pathway—HLA-B—Graves' disease	0.00569	0.0262	CbGpPWpGaD
Lapatinib—Leukopenia—Methimazole—Graves' disease	0.00552	0.0411	CcSEcCtD
Lapatinib—TAP1—Type II interferon signaling (IFNG)—IFNG—Graves' disease	0.00538	0.0248	CbGpPWpGaD
Lapatinib—Alopecia—Propylthiouracil—Graves' disease	0.00532	0.0397	CcSEcCtD
Lapatinib—TAP1—ER-Phagosome pathway—HLA-A—Graves' disease	0.00527	0.0243	CbGpPWpGaD
Lapatinib—Myalgia—Methimazole—Graves' disease	0.00525	0.0391	CcSEcCtD
Lapatinib—Arthralgia—Methimazole—Graves' disease	0.00525	0.0391	CcSEcCtD
Lapatinib—ERBB4—EV release from cardiac cells and their functional effects—TNF—Graves' disease	0.00489	0.0225	CbGpPWpGaD
Lapatinib—TAP1—Type II interferon signaling (IFNG)—IL1B—Graves' disease	0.0048	0.0221	CbGpPWpGaD
Lapatinib—TAP1—Antigen processing-Cross presentation—HLA-B—Graves' disease	0.0047	0.0217	CbGpPWpGaD
Lapatinib—Leukopenia—Propylthiouracil—Graves' disease	0.00469	0.035	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Methimazole—Graves' disease	0.00458	0.0342	CcSEcCtD
Lapatinib—Myalgia—Propylthiouracil—Graves' disease	0.00446	0.0333	CcSEcCtD
Lapatinib—Arthralgia—Propylthiouracil—Graves' disease	0.00446	0.0333	CcSEcCtD
Lapatinib—Dyspepsia—Methimazole—Graves' disease	0.00443	0.033	CcSEcCtD
Lapatinib—TAP1—Antigen processing-Cross presentation—HLA-A—Graves' disease	0.00436	0.0201	CbGpPWpGaD
Lapatinib—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.0039	0.0291	CcSEcCtD
Lapatinib—Dyspepsia—Propylthiouracil—Graves' disease	0.00377	0.0281	CcSEcCtD
Lapatinib—Pruritus—Methimazole—Graves' disease	0.00356	0.0265	CcSEcCtD
Lapatinib—PIK3C2B—DNA Damage Response (only ATM dependent)—FASLG—Graves' disease	0.00331	0.0153	CbGpPWpGaD
Lapatinib—Vomiting—Methimazole—Graves' disease	0.0032	0.0238	CcSEcCtD
Lapatinib—Rash—Methimazole—Graves' disease	0.00317	0.0236	CcSEcCtD
Lapatinib—Dermatitis—Methimazole—Graves' disease	0.00317	0.0236	CcSEcCtD
Lapatinib—Headache—Methimazole—Graves' disease	0.00315	0.0235	CcSEcCtD
Lapatinib—EGFR—Arf6 signaling events—TSHR—Graves' disease	0.00314	0.0145	CbGpPWpGaD
Lapatinib—Pruritus—Propylthiouracil—Graves' disease	0.00303	0.0226	CcSEcCtD
Lapatinib—Nausea—Methimazole—Graves' disease	0.00299	0.0223	CcSEcCtD
Lapatinib—TAP1—Direct p53 effectors—FAS—Graves' disease	0.00283	0.013	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.00273	0.0126	CbGpPWpGaD
Lapatinib—Vomiting—Propylthiouracil—Graves' disease	0.00272	0.0203	CcSEcCtD
Lapatinib—Rash—Propylthiouracil—Graves' disease	0.0027	0.0201	CcSEcCtD
Lapatinib—Dermatitis—Propylthiouracil—Graves' disease	0.0027	0.0201	CcSEcCtD
Lapatinib—Headache—Propylthiouracil—Graves' disease	0.00268	0.02	CcSEcCtD
Lapatinib—PI4KB—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.00263	0.0121	CbGpPWpGaD
Lapatinib—TAP1—Class I MHC mediated antigen processing & presentation—HLA-E—Graves' disease	0.00263	0.0121	CbGpPWpGaD
Lapatinib—CYP2C8—pituitary gland—Graves' disease	0.0026	0.0145	CbGeAlD
Lapatinib—Nausea—Propylthiouracil—Graves' disease	0.00254	0.0189	CcSEcCtD
Lapatinib—CYP3A5—adipose tissue—Graves' disease	0.00234	0.013	CbGeAlD
Lapatinib—TAP1—Class I MHC mediated antigen processing & presentation—HLA-B—Graves' disease	0.00188	0.00865	CbGpPWpGaD
Lapatinib—TAP1—Class I MHC mediated antigen processing & presentation—HLA-A—Graves' disease	0.00174	0.00802	CbGpPWpGaD
Lapatinib—ERBB2—DAP12 signaling—HLA-E—Graves' disease	0.0014	0.00643	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 signaling—HLA-E—Graves' disease	0.00137	0.00634	CbGpPWpGaD
Lapatinib—ERBB2—DNA Damage Response (only ATM dependent)—FASLG—Graves' disease	0.00135	0.00621	CbGpPWpGaD
Lapatinib—ERBB2—DAP12 interactions—HLA-E—Graves' disease	0.00131	0.00605	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—HLA-E—Graves' disease	0.0013	0.00601	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 interactions—HLA-E—Graves' disease	0.00129	0.00596	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—CD40—Graves' disease	0.00127	0.00587	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—CTLA4—Graves' disease	0.00126	0.00579	CbGpPWpGaD
Lapatinib—ABCB1—pituitary gland—Graves' disease	0.00125	0.00695	CbGeAlD
Lapatinib—ABCB1—adipose tissue—Graves' disease	0.00124	0.00692	CbGeAlD
Lapatinib—PIK3C2B—Metabolism—GC—Graves' disease	0.00121	0.0056	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—GC—Graves' disease	0.00117	0.00541	CbGpPWpGaD
Lapatinib—ABCB1—thyroid gland—Graves' disease	0.00107	0.00599	CbGeAlD
Lapatinib—EGFR—SHP2 signaling—IL2RA—Graves' disease	0.00103	0.00477	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—HLA-DQB1—Graves' disease	0.00103	0.00477	CbGpPWpGaD
Lapatinib—ERBB2—Leptin signaling pathway—IL1B—Graves' disease	0.00103	0.00473	CbGpPWpGaD
Lapatinib—TAP1—Immune System—IFIH1—Graves' disease	0.00101	0.00463	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—CD8A—Graves' disease	0.000966	0.00445	CbGpPWpGaD
Lapatinib—ERBB2—DAP12 interactions—HLA-B—Graves' disease	0.000936	0.00431	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—HLA-B—Graves' disease	0.000929	0.00428	CbGpPWpGaD
Lapatinib—EGFR—Thromboxane A2 receptor signaling—ICAM1—Graves' disease	0.000923	0.00425	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 interactions—HLA-B—Graves' disease	0.000922	0.00425	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—B3GNT2—Graves' disease	0.000921	0.00424	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—B3GNT2—Graves' disease	0.000889	0.0041	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—HLA-A—Graves' disease	0.000861	0.00397	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.00086	0.00397	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.00083	0.00382	CbGpPWpGaD
Lapatinib—EGFR—Aryl Hydrocarbon Receptor Pathway—IFNG—Graves' disease	0.000822	0.00379	CbGpPWpGaD
Lapatinib—TAP1—Immune System—HLA-E—Graves' disease	0.000791	0.00365	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000786	0.00362	CbGpPWpGaD
Lapatinib—TAP1—Immune System—CD40—Graves' disease	0.000773	0.00356	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—CXCL10—Graves' disease	0.000767	0.00354	CbGpPWpGaD
Lapatinib—TAP1—Immune System—CTLA4—Graves' disease	0.000762	0.00351	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—ICAM1—Graves' disease	0.000755	0.00348	CbGpPWpGaD
Lapatinib—EGFR—Aryl Hydrocarbon Receptor Pathway—IL1B—Graves' disease	0.000733	0.00338	CbGpPWpGaD
Lapatinib—EGFR—SHP2 signaling—IFNG—Graves' disease	0.000683	0.00315	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—HLA-E—Graves' disease	0.000675	0.00311	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—IFIH1—Graves' disease	0.000648	0.00299	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—IFIH1—Graves' disease	0.000639	0.00294	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—HLA-E—Graves' disease	0.000635	0.00293	CbGpPWpGaD
Lapatinib—TAP1—Immune System—HLA-DQB1—Graves' disease	0.000627	0.00289	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—HLA-E—Graves' disease	0.000611	0.00282	CbGpPWpGaD
Lapatinib—EGFR—Regulation of Telomerase—IFNG—Graves' disease	0.000601	0.00277	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—CD40—Graves' disease	0.000597	0.00275	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—CTLA4—Graves' disease	0.000588	0.00271	CbGpPWpGaD
Lapatinib—TAP1—Immune System—CD8A—Graves' disease	0.000586	0.0027	CbGpPWpGaD
Lapatinib—TAP1—Immune System—HLA-B—Graves' disease	0.000564	0.0026	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—CD4—Graves' disease	0.000555	0.00256	CbGpPWpGaD
Lapatinib—EGFR—Aryl Hydrocarbon Receptor—TNF—Graves' disease	0.000532	0.00245	CbGpPWpGaD
Lapatinib—EGFR—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	0.000532	0.00245	CbGpPWpGaD
Lapatinib—TAP1—Immune System—IL2RA—Graves' disease	0.000528	0.00243	CbGpPWpGaD
Lapatinib—TAP1—Immune System—HLA-A—Graves' disease	0.000522	0.00241	CbGpPWpGaD
Lapatinib—EGFR—Direct p53 effectors—FAS—Graves' disease	0.000514	0.00237	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—HLA-E—Graves' disease	0.00051	0.00235	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—ICAM1—Graves' disease	0.000508	0.00234	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—HLA-E—Graves' disease	0.000503	0.00232	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—HLA-E—Graves' disease	0.00049	0.00226	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—HLA-DQB1—Graves' disease	0.000485	0.00223	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—HLA-E—Graves' disease	0.000483	0.00222	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—CD40—Graves' disease	0.000479	0.00221	CbGpPWpGaD
Lapatinib—TAP1—Immune System—HLA-DRB1—Graves' disease	0.000477	0.0022	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—CTLA4—Graves' disease	0.000472	0.00218	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—CD40—Graves' disease	0.000472	0.00217	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—CTLA4—Graves' disease	0.000465	0.00214	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—FASLG—Graves' disease	0.000461	0.00212	CbGpPWpGaD
Lapatinib—TAP1—Immune System—ICAM1—Graves' disease	0.000458	0.00211	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—HLA-B—Graves' disease	0.000452	0.00208	CbGpPWpGaD
Lapatinib—ERBB2—Disease—B3GNT2—Graves' disease	0.000448	0.00206	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—FAS—Graves' disease	0.000444	0.00205	CbGpPWpGaD
Lapatinib—ERBB4—Disease—B3GNT2—Graves' disease	0.000441	0.00203	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—HLA-B—Graves' disease	0.000435	0.00201	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—FASLG—Graves' disease	0.000425	0.00196	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.000416	0.00192	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—FAS—Graves' disease	0.00041	0.00189	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—IL2RA—Graves' disease	0.000408	0.00188	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—HLA-A—Graves' disease	0.000403	0.00186	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000401	0.00185	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000389	0.00179	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—IFNG—Graves' disease	0.000387	0.00178	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000383	0.00176	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IFIH1—Graves' disease	0.000378	0.00174	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IFIH1—Graves' disease	0.000372	0.00171	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—HLA-DRB1—Graves' disease	0.000368	0.0017	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—HLA-B—Graves' disease	0.000364	0.00168	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—CD8A—Graves' disease	0.000363	0.00167	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—HLA-B—Graves' disease	0.000358	0.00165	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—CD8A—Graves' disease	0.000357	0.00165	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	0.000352	0.00162	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—HLA-B—Graves' disease	0.000349	0.00161	CbGpPWpGaD
Lapatinib—TAP1—Immune System—IFNG—Graves' disease	0.000348	0.00161	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—IL1B—Graves' disease	0.000345	0.00159	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—HLA-B—Graves' disease	0.000344	0.00158	CbGpPWpGaD
Lapatinib—TAP1—Immune System—CD4—Graves' disease	0.000336	0.00155	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—HLA-A—Graves' disease	0.000323	0.00149	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—HLA-A—Graves' disease	0.000319	0.00147	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—IFIH1—Graves' disease	0.000314	0.00144	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000311	0.00143	CbGpPWpGaD
Lapatinib—TAP1—Immune System—IL1B—Graves' disease	0.000311	0.00143	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—HLA-E—Graves' disease	0.000297	0.00137	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000296	0.00136	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—HLA-E—Graves' disease	0.000293	0.00135	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000291	0.00134	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CD40—Graves' disease	0.00029	0.00134	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CTLA4—Graves' disease	0.000286	0.00132	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CD40—Graves' disease	0.000286	0.00132	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—ICAM1—Graves' disease	0.000284	0.00131	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CTLA4—Graves' disease	0.000282	0.0013	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—ICAM1—Graves' disease	0.000279	0.00129	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000278	0.00128	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—IFNG—Graves' disease	0.000269	0.00124	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—IL1B—Graves' disease	0.00026	0.0012	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TSHR—Graves' disease	0.00026	0.0012	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TSHR—Graves' disease	0.000256	0.00118	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—TNF—Graves' disease	0.00025	0.00115	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—HLA-E—Graves' disease	0.000247	0.00114	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—IL1B—Graves' disease	0.00024	0.00111	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00024	0.0011	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—HLA-E—Graves' disease	0.000237	0.00109	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—HLA-DQB1—Graves' disease	0.000236	0.00109	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—HLA-DQB1—Graves' disease	0.000232	0.00107	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD40—Graves' disease	0.000231	0.00107	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CTLA4—Graves' disease	0.000228	0.00105	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CD8A—Graves' disease	0.00022	0.00101	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—CD4—Graves' disease	0.000217	0.001	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CD8A—Graves' disease	0.000217	0.000999	CbGpPWpGaD
Lapatinib—EGFR—Disease—B3GNT2—Graves' disease	0.000216	0.000997	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—CD4—Graves' disease	0.000214	0.000985	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—TSHR—Graves' disease	0.000213	0.00098	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—HLA-B—Graves' disease	0.000212	0.000976	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.00021	0.000968	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—HLA-B—Graves' disease	0.000209	0.000961	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—CD4—Graves' disease	0.000208	0.000961	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—CD4—Graves' disease	0.000205	0.000946	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000202	0.000933	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL2RA—Graves' disease	0.000198	0.000914	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—HLA-A—Graves' disease	0.000196	0.000904	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL2RA—Graves' disease	0.000195	0.000901	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—HLA-A—Graves' disease	0.000193	0.000891	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TNF—Graves' disease	0.000189	0.00087	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000188	0.000866	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IFIH1—Graves' disease	0.000183	0.000842	CbGpPWpGaD
Lapatinib—ERBB2—Disease—HLA-A—Graves' disease	0.000181	0.000835	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—HLA-DRB1—Graves' disease	0.000179	0.000826	CbGpPWpGaD
Lapatinib—ERBB4—Disease—HLA-A—Graves' disease	0.000178	0.000822	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—HLA-DRB1—Graves' disease	0.000177	0.000814	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—HLA-B—Graves' disease	0.000176	0.00081	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD8A—Graves' disease	0.000175	0.000809	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—TNF—Graves' disease	0.000174	0.000803	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—ICAM1—Graves' disease	0.000172	0.000793	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	0.00017	0.000785	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—ICAM1—Graves' disease	0.000169	0.000781	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—HLA-B—Graves' disease	0.000169	0.000778	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CXCL10—Graves' disease	0.000168	0.000774	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CXCL10—Graves' disease	0.000165	0.000762	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—TNF—Graves' disease	0.000165	0.000759	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GC—Graves' disease	0.00016	0.000737	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—HLA-A—Graves' disease	0.000156	0.000721	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HLA-E—Graves' disease	0.000144	0.000662	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000143	0.000658	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD40—Graves' disease	0.00014	0.000647	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GC—Graves' disease	0.000139	0.000639	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CTLA4—Graves' disease	0.000138	0.000638	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CXCL10—Graves' disease	0.000137	0.000633	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—ICAM1—Graves' disease	0.000137	0.000632	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IFNG—Graves' disease	0.000131	0.000603	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IFNG—Graves' disease	0.000129	0.000594	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL2RA—Graves' disease	0.000128	0.000591	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CD4—Graves' disease	0.000126	0.000583	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL2RA—Graves' disease	0.000126	0.000582	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TSHR—Graves' disease	0.000126	0.000579	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CD4—Graves' disease	0.000125	0.000574	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GC—Graves' disease	0.000124	0.00057	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—B3GNT2—Graves' disease	0.000121	0.000559	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GC—Graves' disease	0.000121	0.000556	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL1B—Graves' disease	0.000117	0.000538	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CD4—Graves' disease	0.000117	0.000538	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL1B—Graves' disease	0.000115	0.00053	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CD4—Graves' disease	0.000115	0.00053	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HLA-DQB1—Graves' disease	0.000114	0.000525	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD8A—Graves' disease	0.000106	0.00049	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—B3GNT2—Graves' disease	0.000105	0.000484	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL2RA—Graves' disease	0.000105	0.000484	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CD4—Graves' disease	0.000105	0.000484	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HLA-B—Graves' disease	0.000102	0.000472	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD4—Graves' disease	0.000101	0.000464	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL2RA—Graves' disease	9.59e-05	0.000442	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HLA-A—Graves' disease	9.48e-05	0.000437	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—B3GNT2—Graves' disease	9.37e-05	0.000432	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—B3GNT2—Graves' disease	9.15e-05	0.000422	CbGpPWpGaD
Lapatinib—EGFR—Disease—HLA-A—Graves' disease	8.76e-05	0.000404	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HLA-DRB1—Graves' disease	8.66e-05	0.000399	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	8.6e-05	0.000396	CbGpPWpGaD
Lapatinib—EGFR—Immune System—ICAM1—Graves' disease	8.32e-05	0.000383	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CXCL10—Graves' disease	8.11e-05	0.000374	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TNF—Graves' disease	7.96e-05	0.000367	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GC—Graves' disease	7.44e-05	0.000343	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IFNG—Graves' disease	6.33e-05	0.000292	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL2RA—Graves' disease	6.2e-05	0.000286	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD4—Graves' disease	6.11e-05	0.000282	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL1B—Graves' disease	5.64e-05	0.00026	CbGpPWpGaD
Lapatinib—EGFR—Disease—CD4—Graves' disease	5.64e-05	0.00026	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—B3GNT2—Graves' disease	5.64e-05	0.00026	CbGpPWpGaD
